http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Twist Alliance Pan-Cancer Methylation Panel Global Launch Event - A Strategic Collaboration Between AnchorDx and Twist Bioscience for Pan-Cancer Liquid Biopsy
-
Twist Bioscience Corporation (TWST), CENTOGENE (CNTG) to Develop Advanced Sequencing Tools to Make Genetic Testing Rapidly Accessible for More Patients With Rare Diseases
-
CENTOGENE and Twist Bioscience to Develop Advanced Sequencing Tools to Make Genetic Testing Rapidly Accessible for More Patients With Rare Diseases
-
CENTOGENE and Twist Bioscience to Develop Advanced Sequencing Tools to Make Genetic Testing Rapidly Accessible for More Patients With Rare Diseases
-
Twist Bioscience and CENTOGENE to Develop Advanced Sequencing Tools to Make Genetic Testing Rapidly Accessible for More Patients With Rare Diseases
-
Twist Bioscience Expands Expert Custom Alliance Panel Offering
-
Twist Bioscience Appoints Dennis Cho as Senior Vice President, General Counsel and Chief Ethics and Compliance Officer
-
Twist Bioscience Corporation (TWST) Internally-Discovered Single Domain Antibody TB202-3 Shows Potent Binding to Multiple Strains of COVID-19
-
Twist Bioscience Internally-Discovered Single Domain Antibody TB202-3 Shows Potent Binding to Multiple Strains of SARS-CoV-2, Including Alpha, Beta, and Gamma Strains, in Preclinical Studies
-
Twist Bioscience Collaborates with Deep Learning Experts deepCDR on Antibody Library Design
-
Twist Bioscience Corporation (TWST) has started shipping its synthetic RNA reference controls for the SARS-CoV-2 AY.1 and AY.2, more commonly known as Delta Plus
-
Twist Bioscience Continues Commitment to Deliver Synthetic RNA Controls, now to Fight Delta Plus Variants of COVID-19
-
ACETO Corp (ACET) Collaborates with Twist Bioscience (TWST) to Accelerate Discovery of Gamma Delta T Cell Cancer Therapeutics
-
Twist Bioscience Collaborates with Adicet Bio to Accelerate Discovery of Gamma Delta T Cell Cancer Therapeutics
-
Adicet Bio Collaborates with Twist Bioscience to Accelerate Discovery of Gamma Delta T Cell Cancer Therapeutics
-
Twist Bioscience Corporation (TWST), Boehringer Ingelheim Enter Therapeutic Antibody Discovery Collaboration
-
Boehringer Ingelheim and Twist Bioscience Enter Therapeutic Antibody Discovery Collaboration
-
Twist Bioscience to Present at Baird 2021 Global Healthcare Conference
-
SomaLogic and Twist Bioscience Corporation (TWST) announce partnership to discover novel therapeutic targets and antibodies
-
SomaLogic and Twist Bioscience Corporation announce partnership to discover novel therapeutic targets and antibodies
-
SomaLogic and Twist Bioscience Corporation announce partnership to discover novel therapeutic targets and antibodies
-
Twist Bioscience to Present at UBS Genomics 2.0 and Medtech Innovations Summit
-
Twist Bioscience Reports Third Quarter Fiscal 2021 Financial Results
-
Twist Bioscience (TWST) Appoints Drug Discovery Leader Melissa Starovasnik, Ph.D., to Board of Directors
-
Twist Bioscience Appoints Drug Discovery Leader Melissa Starovasnik, Ph.D., to Board of Directors
-
Twist Bioscience Incorporates MOLCURE AI Technology to Augment Therapeutic Antibody Discovery
-
Sema4 Closes Transaction with CM Life Sciences, Debuts as Publicly Traded AI-driven Genomic & Clinical Data Platform Company
-
Twist Bioscience Corporation (TWST) Now Shipping Synthetic RNA Positive Controls for Delta (B.1.617.2) SARS-CoV-2 Variant for Development of Accurate Diagnostic Tests
-
Twist Bioscience Now Shipping Synthetic RNA Positive Controls for Delta (B.1.617.2) SARS-CoV-2 Variant for Development of Accurate Diagnostic Tests
-
Twist Bioscience to Report Fiscal 2021 Third Quarter Financial Results on Friday, August 6, 2021
-
Former Magenta Therapeutics and Foundation Medicine CFO Jason Ryan to Join Sema4 Board of Directors
-
Twist Bioscience Corporation (TWST) cquires NGS Library Preparation Maker iGenomX
-
Twist Bioscience Acquires NGS Library Preparation Maker iGenomX
-
Dovetail Genomics Announces New Capture Hi-C Targeted Enrichment Panels
-
Twist Bioscience Corporation (TWST) Collaborates with Regeneron (REGN) for Production of Genotyping by Sequencing Panel to Enable Diverse Genome-wide Screening
-
Twist Bioscience Collaborates with Regeneron for Production of Genotyping by Sequencing Panel to Enable Diverse Genome-wide Screening
-
Twist Bioscience Announces Fireside Chat and Presentation at BIO Digital
-
DNA Data Storage Alliance Publishes First White Paper, Launches Website
-
Twist Bioscience (TWST) Begins Shipping of Synthetic RNA Controls for Kappa (B.1.617.1) SARS-CoV-2 Variants for Development of Accurate Tests
-
Twist Bioscience Begins Shipping of Synthetic RNA Controls for Kappa (B.1.617.1) SARS-CoV-2 Variants for Development of Accurate Tests
-
Twist Bioscience Launches Enzymatic Fragmentation Library Preparation Kit for High Uniformity, High-Yield Amplification, Streamlined Next Generation Sequencing Workflow for Targeted Applications
-
Twist Bioscience to Present at Upcoming Virtual Conferences
-
Twist Bioscience Supports the Engineering Biology Research Consortium as it Publishes Statement of Ethics
-
Twist Bioscience Reports Second Quarter Fiscal 2021 Financial Results
-
Twist Bioscience Corporation (TWST), Vivlion Partner to Generate gRNA Libraries for CRISPR Applications
-
Twist Bioscience and Vivlion Partner to Generate gRNA Libraries for CRISPR Applications
-
Twist Bioscience to Report Fiscal 2021 Second Quarter Financial Results on Thursday, May 6, 2021
-
Twist Bioscience to Expand Oregon Lease, Supporting Future Growth
-
Pure Biologics Selects Twist Bioscience (TWST) to Expand Phage Display Technology Capabilities
-
Pure Biologics Selects Twist Bioscience to Expand Phage Display Technology Capabilities

